Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00339079 · ClinicalTrials.gov registry record · Phase 1
Treatment of Hypochondriasis With CBT and/or SSRI
A Phase 1 study of Hypochondriasis, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 195
- Enrollment target
- 2
- Study locations
NCT00339079: Completed Phase 1 study of Hypochondriasis, sponsored by Brigham and Women's Hospital.
NCT00339079 is a Phase 1 study of Hypochondriasis that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 195 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (225% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00339079, a Phase 1 study of Hypochondriasis, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 195 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will compare the effectiveness of cognitive behavioral therapy, antidepressant medication, and a combination of the two for treating hypochondriasis.
Primary Outcome
Whitley index is a self-report measure of hypochondriasis H-YBOCS-M is an independent evaluator structured assessment of hypochondriasis
Conditions Studied
Interventions
- DRUG Placebo
- BEHAVIORAL Cognitive Behavioral Therapy (CBT)
- DRUG Fluoxetine
- OTHER Supportive Therapy
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
New York
- Columbia Medical Center, New York Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 195 participants |
| Start Date | 2006-06 |
| Est. Completion | 2011-12 |
| Phase | Phase 1 |
What the finished NCT00339079 record still lists
NCT00339079 is an interventional study that assigns participants to a tested intervention. The registered 195 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (225% higher).
The record links to 1 condition, with Hypochondriasis appearing as the primary indexed condition, and to 4 interventions - of which Placebo is the first listed.
NCT00339079 reports a single indexed study location in Massachusetts, New York.
Frequently Asked Questions
What is clinical trial NCT00339079 about?
NCT00339079 is a clinical study titled "Treatment of Hypochondriasis With CBT and/or SSRI". This study will compare the effectiveness of cognitive behavioral therapy, antidepressant medication, and a combination of the two for treating hypochondriasis.
What is the current status of trial NCT00339079?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 195 participants. The study started on 2006-06. Estimated completion is 2011-12.
What conditions does trial NCT00339079 study?
This clinical trial studies the following conditions: Hypochondriasis.
What interventions are being tested in trial NCT00339079?
The interventions under investigation include: Placebo (DRUG), Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Fluoxetine (DRUG), Supportive Therapy (OTHER).
Who is sponsoring clinical trial NCT00339079?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00339079 being conducted?
This trial has 2 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00339079's enrollment target sits among peer trials
195 281st of 2000 higher than 1,719 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276922 · 195 participants · NA
Creative Arts Program to Reduce Burnout in Healthcare Professionals
- NCT04829357 · 195 participants
Post Market Clinical Follow-up Study on TVT ABBREVO® Continence System
- NCT05054738 · 195 participants · NA
CRP and S&A for Inpatient Veterans
- NCT05561595 · 195 participants · NA
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia